Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathew Thomas

Showing results (191-200 of 259) with videos related to

Pageof 26
Sort By:
Prostate Cancer and Prostatic Diseases|August 24, 2023
Correction: Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitorsGeorges Gebrael, Nicolas Sayegh, Vinay Mathew Thomas, et al.
The Annals of Thoracic Surgery|November 21, 2022
Survival Outcomes of Lung Transplant Recipients From Donors With Abnormal Kidney FunctionMagdy M El-Sayed Ahmed, Sadia Z Shah, Nan Zhang, et al.
Prostate Cancer and Prostatic Diseases|July 17, 2023
Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitorsGeorges Gebrael, Nicolas Sayegh, Vinay Mathew Thomas, et al.
Cancers|June 19, 2024
Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center AnalysisNishita Tripathi, Georges Gebrael, Beverly Chigarira, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|July 19, 2025
Economic burden borne by patients due to diagnostic delays in inflammatory bowel disease: Insights from a survey of newly diagnosed patientsVijesh V S, Noble Varghese Mathews, Nicholas Vijay Rao, et al.
Journal of Thoracic Disease|November 18, 2024
Outcomes of lung volume reduction surgery for emphysema: unilateral and bilateralRocio Castillo-Larios, Alejandra Yu Lee-Mateus, Daniel Hernandez-Rojas, et al.
Bladder Cancer (Amsterdam, Netherlands)|April 1, 2026
Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumabGeorges Gebrael, Yeonjung Jo, Zeynep Irem Ozay, et al.
Journal of Thoracic Disease|June 18, 2025
Evaluating long-term bronchoscopic outcomes of tracheobronchoplasty in patients with expiratory central airway collapseBryan F Vaca-Cartagena, Rodrigo Funes-Ferrada, Alanna Barrios-Ruiz, et al.
Journal of Cardiothoracic and Vascular Anesthesia|September 21, 2021
Outcomes After Lung Retransplantation: A Single-Center Retrospective Cohort StudyRodrigo O L Pereira, Eduardo S Rodrigues, Archer K Martin, et al.
Cancer Medicine|September 4, 2018
Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centersYanyan Lou, Bhagirathbhai Dholaria, Aixa Soyano, et al.
Pageof 26

Showing results (191-200 of 259) with videos related to

Sort By:
Pageof 26
Prostate Cancer and Prostatic Diseases|August 24, 2023
Correction: Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitorsGeorges Gebrael, Nicolas Sayegh, Vinay Mathew Thomas, et al.
The Annals of Thoracic Surgery|November 21, 2022
Survival Outcomes of Lung Transplant Recipients From Donors With Abnormal Kidney FunctionMagdy M El-Sayed Ahmed, Sadia Z Shah, Nan Zhang, et al.
Prostate Cancer and Prostatic Diseases|July 17, 2023
Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitorsGeorges Gebrael, Nicolas Sayegh, Vinay Mathew Thomas, et al.
Cancers|June 19, 2024
Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center AnalysisNishita Tripathi, Georges Gebrael, Beverly Chigarira, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|July 19, 2025
Economic burden borne by patients due to diagnostic delays in inflammatory bowel disease: Insights from a survey of newly diagnosed patientsVijesh V S, Noble Varghese Mathews, Nicholas Vijay Rao, et al.
Journal of Thoracic Disease|November 18, 2024
Outcomes of lung volume reduction surgery for emphysema: unilateral and bilateralRocio Castillo-Larios, Alejandra Yu Lee-Mateus, Daniel Hernandez-Rojas, et al.
Bladder Cancer (Amsterdam, Netherlands)|April 1, 2026
Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumabGeorges Gebrael, Yeonjung Jo, Zeynep Irem Ozay, et al.
Journal of Thoracic Disease|June 18, 2025
Evaluating long-term bronchoscopic outcomes of tracheobronchoplasty in patients with expiratory central airway collapseBryan F Vaca-Cartagena, Rodrigo Funes-Ferrada, Alanna Barrios-Ruiz, et al.
Journal of Cardiothoracic and Vascular Anesthesia|September 21, 2021
Outcomes After Lung Retransplantation: A Single-Center Retrospective Cohort StudyRodrigo O L Pereira, Eduardo S Rodrigues, Archer K Martin, et al.
Cancer Medicine|September 4, 2018
Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centersYanyan Lou, Bhagirathbhai Dholaria, Aixa Soyano, et al.
Pageof 26